Saliva test to predict premature births:
This article was originally published in Clinica
Biex's SalEst saliva test has obtained FDA marketing approval for use in predicting premature birth in third-trimester women. SalEst measures the level of the hormone estriol, which appears in saliva a few weeks before spontaneous pre-term labour occurs. The test, which will be available later this year, identifies the "vast majority" of affected women, says Dublin, California-based Biex, compared with the less than 50% accuracy of traditional risk scoring systems. It will be the company's first product.